18F-PSMA

DRUG3 trials

Sponsors

University Hospital, Ghent, Alessandro D'Agnolo, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Conditions

18F-PSMAGenital Diseases, MaleGenital Neoplasms, MaleNeoplasmsNeoplasms by SiteProstate CancerProstatic DiseaseProstatic Neoplasms

Phase 1

PSMA-PET/CT for Prostate Cancer

CompletedNCT03558711

University Hospital, GhentProstate Cancer

Start: 2018-01-04End: 2018-03-29Updated: 2024-09-19

Phase 2

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

TerminatedNCT04461509

Alessandro D'AgnoloGenital Diseases, Male, Genital Neoplasms, Male, Neoplasms +4

Start: 2021-04-06End: 2024-09-03Updated: 2026-07-22

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer.

CompletedNCT04775602

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS18F-PSMA, Prostate Cancer

Start: 2020-07-31End: 2024-07-11Updated: 2025-01-09